{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:09:34Z","timestamp":1767154174789,"version":"build-2238731810"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The digestive tract is a common site of extranodal malignant lymphomas (MLs) and benign lymphoid lesions (BLs). TP53-binding protein 1 (53BP1) expression has been widely investigated in class switch recombination but rarely in human lymphoid tissues with respect to tumorigenesis. We previously reported that immunofluorescence (IF) analysis of 53BP1 nuclear foci (NF), reflecting DNA double strand breaks, is useful for estimating genomic instability in different tumor types. In this study, we evaluated the potential of IF-based analysis of 53BP1 expression in differentiating MLs from BLs. We examined 231 biopsied tissue samples of primary MLs and BLs in the digestive tract. The 53BP1 immunoreactivity pattern was determined by multicolor IF. Compared to BLs, MLs showed a high frequency of abnormal 53BP1 expression (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Statistically, abnormal 53BP1 expression is an effective test for distinguishing follicular lymphomas from BLs (specificity 98.6%, sensitivity 86.8%) and for distinguishing small B-cell lymphomas from BLs (specificity 98.3%, sensitivity 77.6%). Furthermore, a high frequency of abnormal 53BP1 expression was associated with \u201chigh-risk\u201d MALT lymphomas, which exhibited t(11;18)(q21;21) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0145). Collectively, these results suggest that IF-based analysis of 53BP1 expression in biopsy samples is a promising technique for diagnosing MLs in the digestive system.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-82867-0","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T06:08:10Z","timestamp":1612418890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract"],"prefix":"10.1038","volume":"11","author":[{"given":"Thi My Hanh","family":"Luong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Niino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kurohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"82867_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.canep.2009.09.006","volume":"33","author":"X-C Wu","year":"2009","unstructured":"Wu, X.-C., Andrews, P., Chen, V. W. & Groves, F. D. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians\/Pacific Islanders in the United States: Anatomic site and histology differences. Cancer Epidemiol. 33, 337\u2013346 (2009).","journal-title":"Cancer Epidemiol."},{"key":"82867_CR2","doi-asserted-by":"crossref","unstructured":"Zucca, E., Roggero, E., Bertoni, F. & Cavalli, F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann. Oncol. 8, 727\u2013737 (1997).","DOI":"10.1023\/A:1008282818705"},{"key":"82867_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/annonc\/mdg004","volume":"14","author":"A Krol","year":"2003","unstructured":"Krol, A. et al. Primary extranodal non-Hodgkin\u2019s lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann. Oncol. 14, 131\u2013139 (2003).","journal-title":"Ann. Oncol."},{"key":"82867_CR4","unstructured":"Finke, D. in Seminars in Immunopathology. 151\u2013169 (Springer)."},{"key":"82867_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1385\/IR:33:2:167","volume":"33","author":"RT Taylor","year":"2005","unstructured":"Taylor, R. T. & Williams, I. R. Lymphoid organogenesis in the intestine. Immunol. Res. 33, 167\u2013181 (2005).","journal-title":"Immunol. Res."},{"key":"82867_CR6","first-page":"201","volume":"3","author":"K Jaskiewicz","year":"2000","unstructured":"Jaskiewicz, K. & Kobierska, G. Lymphoid aggregates in gastric biopsies: Relationship to other mucosal lesions. Arch. Immunol. Ther. Exp. 3, 201\u2013204 (2000).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"82867_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.anndiagpath.2013.12.006","volume":"18","author":"M Iwamuro","year":"2014","unstructured":"Iwamuro, M. et al. Diagnostic accuracy of endoscopic biopsies for the diagnosis of gastrointestinal follicular lymphoma: A clinicopathologic study of 48 patients. Ann. Diagn. Pathol. 18, 99\u2013103 (2014).","journal-title":"Ann. Diagn. Pathol."},{"key":"82867_CR8","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0092-8674(02)00675-X","volume":"109","author":"CH Bassing","year":"2002","unstructured":"Bassing, C. H., Swat, W. & Alt, F. W. The mechanism and regulation of chromosomal V (D) J recombination. Cell 109, S45\u2013S55 (2002).","journal-title":"Cell"},{"key":"82867_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","volume":"20","author":"T Honjo","year":"2002","unstructured":"Honjo, T., Kinoshita, K. & Muramatsu, M. Molecular mechanism of class switch recombination: Linkage with somatic hypermutation. Annu. Rev. Immunol. 20, 165\u2013196 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"82867_CR10","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/1521-4141(2002010)32:10<2792::AID-IMMU2792>3.0.CO;2-I","volume":"32","author":"TT Li","year":"2002","unstructured":"Li, T. T., Han, S., Cubbage, M. & Zheng, B. Continued expression of recombination-activating genes and TCR gene recombination in human peripheral T cells. Eur. J. Immunol. 32, 2792\u20132799 (2002).","journal-title":"Eur. J. Immunol."},{"key":"82867_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1096\/fasebj.11.1.9034168","volume":"11","author":"P Bork","year":"1997","unstructured":"Bork, P. et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11, 68\u201376 (1997).","journal-title":"FASEB J."},{"key":"82867_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1101\/gad.959202","volume":"16","author":"WS Joo","year":"2002","unstructured":"Joo, W. S. et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16, 583\u2013593 (2002).","journal-title":"Genes Dev."},{"key":"82867_CR13","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1128\/MCB.21.5.1719-1729.2001","volume":"21","author":"L Anderson","year":"2001","unstructured":"Anderson, L., Henderson, C. & Adachi, Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell. Biol. 21, 1719\u20131729 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"82867_CR14","doi-asserted-by":"publisher","first-page":"19579","DOI":"10.1074\/jbc.C300117200","volume":"278","author":"IM Ward","year":"2003","unstructured":"Ward, I. M., Minn, K., Jorda, K. G. & Chen, J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 278, 19579\u201319582 (2003).","journal-title":"J. Biol. Chem."},{"key":"82867_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.153.3.613","volume":"153","author":"I Rappold","year":"2001","unstructured":"Rappold, I., Iwabuchi, K., Date, T. & Chen, J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153, 613\u2013620 (2001).","journal-title":"J. Cell Biol."},{"key":"82867_CR16","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ijc.23223","volume":"122","author":"M Nakashima","year":"2008","unstructured":"Nakashima, M. et al. Foci formation of P53-binding protein 1 in thyroid tumors: Activation of genomic instability during thyroid carcinogenesis. Int. J. Cancer 122, 1082\u20131088 (2008).","journal-title":"Int. J. Cancer"},{"key":"82867_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2559.2011.03963.x","volume":"59","author":"K Matsuda","year":"2011","unstructured":"Matsuda, K. et al. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: Endogenous DNA double strand breaks and genomic instability during carcinogenesis. Histopathology 59, 441\u2013451 (2011).","journal-title":"Histopathology"},{"key":"82867_CR18","first-page":"1","volume":"8","author":"K Matsuda","year":"2018","unstructured":"Matsuda, K. et al. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma. Sci. Rep. 8, 1\u20139 (2018).","journal-title":"Sci. Rep."},{"key":"82867_CR19","doi-asserted-by":"crossref","unstructured":"Mussazhanova, Z. et al. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid. Endocr. J. EJ15\u20130629 (2016).","DOI":"10.1507\/endocrj.EJ15-0629"},{"key":"82867_CR20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/his.12233","volume":"63","author":"Z Mussazhanova","year":"2013","unstructured":"Mussazhanova, Z. et al. Significance of p53-binding protein 1 (53 BP 1) expression in thyroid papillary microcarcinoma: Association with BRAFV 600E mutation status. Histopathology 63, 726\u2013734 (2013).","journal-title":"Histopathology"},{"key":"82867_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1349-7006.2008.00786.x","volume":"99","author":"Y Naruke","year":"2008","unstructured":"Naruke, Y. et al. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Cancer Sci. 99, 946\u2013951 (2008).","journal-title":"Cancer Sci."},{"key":"82867_CR22","doi-asserted-by":"crossref","unstructured":"Stavnezer, J., Guikema, J. E. & Schrader, C. E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26 (2008).","DOI":"10.1146\/annurev.immunol.26.021607.090248"},{"key":"82867_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ni1067","volume":"5","author":"JP Manis","year":"2004","unstructured":"Manis, J. P. et al. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat. Immunol. 5, 481\u2013487 (2004).","journal-title":"Nat. Immunol."},{"key":"82867_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molcel.2009.04.025","volume":"34","author":"E Call\u00e9n","year":"2009","unstructured":"Call\u00e9n, E. et al. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol. Cell 34, 285\u2013297 (2009).","journal-title":"Mol. Cell"},{"key":"82867_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.200403021","volume":"165","author":"IM Ward","year":"2004","unstructured":"Ward, I. M. et al. 53BP1 is required for class switch recombination. J. Cell Biol. 165, 459\u2013464 (2004).","journal-title":"J. Cell Biol."},{"key":"82867_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molcel.2011.03.019","volume":"42","author":"A Bothmer","year":"2011","unstructured":"Bothmer, A. et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell 42, 319\u2013329 (2011).","journal-title":"Mol. Cell"},{"key":"82867_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.molcel.2012.11.029","volume":"49","author":"M Jankovic","year":"2013","unstructured":"Jankovic, M. et al. 53BP1 alters the landscape of DNA rearrangements and suppresses AID-induced B cell lymphoma. Mol. Cell 49, 623\u2013631 (2013).","journal-title":"Mol. Cell"},{"key":"82867_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/thy.2018.0548","volume":"29","author":"R Otsubo","year":"2019","unstructured":"Otsubo, R. et al. A novel diagnostic method for thyroid follicular tumors based on immunofluorescence analysis of p53-binding protein 1 expression: Detection of genomic instability. Thyroid 29, 657\u2013665 (2019).","journal-title":"Thyroid"},{"key":"82867_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2009.11.007","volume":"36","author":"DF Robbiani","year":"2009","unstructured":"Robbiani, D. F. et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 36, 631\u2013641 (2009).","journal-title":"Mol. Cell"},{"key":"82867_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864\u2013870 (2005).","journal-title":"Nature"},{"key":"82867_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/modpathol.2017.58","volume":"30","author":"A Onaindia","year":"2017","unstructured":"Onaindia, A., Medeiros, L. J. & Patel, K. P. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms. Mod. Pathol. 30, 1338\u20131366 (2017).","journal-title":"Mod. Pathol."},{"key":"82867_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","volume":"246","author":"KH Lim","year":"2012","unstructured":"Lim, K. H., Yang, Y. & Staudt, L. M. Pathogenetic importance and therapeutic implications of NF-\u03baB in lymphoid malignancies. Immunol. Rev. 246, 359\u2013378 (2012).","journal-title":"Immunol. Rev."},{"key":"82867_CR33","doi-asserted-by":"crossref","unstructured":"Adamowicz, M., Vermezovic, J. & di Fagagna, F. d. A. NOTCH1 inhibits activation of ATM by impairing the formation of an ATM-FOXO3a-KAT5\/Tip60 complex. Cell Rep. 16, 2068\u20132076 (2016).","DOI":"10.1016\/j.celrep.2016.07.038"},{"key":"82867_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115\u2013119 (2011).","journal-title":"Nature"},{"key":"82867_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N. Engl. J. Med. 367, 826\u2013833 (2012).","journal-title":"N. Engl. J. Med."},{"key":"82867_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2014.01.023","volume":"356","author":"S Havaki","year":"2015","unstructured":"Havaki, S. et al. The role of oxidative DNA damage in radiation induced bystander effect. Cancer Lett. 356, 43\u201351 (2015).","journal-title":"Cancer Lett."},{"key":"82867_CR37","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.5858\/arpa.2011-0145-RA","volume":"135","author":"JS Burke","year":"2011","unstructured":"Burke, J. S. Lymphoproliferative disorders of the gastrointestinal tract: A review and pragmatic guide to diagnosis. Arch. Pathol. Lab. Med. 135, 1283\u20131297 (2011).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"82867_CR38","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1309\/B6MK-J7NF-A6JP-X56K","volume":"115","author":"C Eshoa","year":"2001","unstructured":"Eshoa, C. et al. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. Am. J. Clin. Pathol. 115, 862\u2013867 (2001).","journal-title":"Am. J. Clin. Pathol."},{"key":"82867_CR39","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","volume":"19","author":"Y Guo","year":"2005","unstructured":"Guo, Y. et al. Low-grade follicular lymphoma with t (14; 18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 19, 1058\u20131063 (2005).","journal-title":"Leukemia"},{"key":"82867_CR40","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","volume":"109","author":"K Karube","year":"2007","unstructured":"Karube, K. et al. CD10\u2212 MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 109, 3076\u20133079 (2007).","journal-title":"Blood"},{"key":"82867_CR41","doi-asserted-by":"crossref","unstructured":"Hosmer, D. W. Assessing the fit of the model. Appl. Logist. Regress. 143\u2013202 (2000).","DOI":"10.1002\/0471722146.ch5"},{"key":"82867_CR42","unstructured":"Swerdlow, S., Cook, J. & Sohani, A. Lymphoplasmacytic Lymphoma: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn 232\u2013235 (World Health Organization, Lyon, International Agency for Research on Cancer, 2017)."},{"key":"82867_CR43","doi-asserted-by":"crossref","unstructured":"Liu, H. et al. T (11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122, 1286\u20131294 (2002).","DOI":"10.1053\/gast.2002.33047"},{"key":"82867_CR44","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1097\/00000478-200412000-00003","volume":"28","author":"H Inagaki","year":"2004","unstructured":"Inagaki, H. et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am. J. Surg. Pathol. 28, 1560\u20131567 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"82867_CR45","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00277-019-03671-5","volume":"98","author":"K Toyoda","year":"2019","unstructured":"Toyoda, K. et al. Mucosa-associated lymphoid tissue lymphoma with t (11; 18)(q21; q21) translocation: long-term follow-up results. Ann. Hematol. 98, 1675\u20131687 (2019).","journal-title":"Ann. Hematol."}],"updated-by":[{"DOI":"10.1038\/s41598-021-91766-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82867-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82867-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82867-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:14:56Z","timestamp":1697775296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82867-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82867"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82867-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-91766-3","URL":"https:\/\/doi.org\/10.1038\/s41598-021-91766-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3074"}}